BK病毒感染:对管理和治疗的审查
June Hayrelle Gorriceta1, Amy Lopez Otbo2, Genta Uehara3
1Department of Medicine, St Francis Hospital-Bartlett, Bartlett, TN 38133, United States.
World journal of transplantation
|January 4, 2024
概括
移植后的BK病毒感染具有挑战性. 虽然降低免疫抑制是关键,但像IV免疫球蛋白和T细胞疗法这样的新选择对治疗移植患者的BK病毒有希望.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 传染性疾病 传染性疾病
- 移植免疫学 移植免疫学
背景情况:
- 在移植后,BK病毒感染是严重的并发症,往往导致移植功能障碍.
- 目前的管理主要涉及减少免疫抑制,其成功率有变化.
- 探索新的治疗策略对于改善BK病毒感染的结果至关重要.
研究的目的:
- 审查移植患者BK病毒感染的当前管理策略.
- 探索超越标准免疫抑制减缓的新兴和替代治疗选择.
- 讨论各种治疗方式的有效性和局限性的最新证据.
主要方法:
- 对移植受体BK病毒感染管理研究的文献综述.
- 对临床试验和观察性研究进行分析,评估不同的治疗干预措施.
- 对各种治疗方法的疗效,安全性和作用机制的综合数据.
主要成果:
- 降低免疫抑制仍然是BK感染管理的基石.
- 诺基诺预防/治疗没有显示任何益处;cidofovir有毒性问题.
- 静脉注射免疫球蛋白 (IVIG) 越来越多地用于预防和治疗,增强中和抗体标位.
- 病毒特异性T细胞疗法是BK病毒病的新兴和有前途的治疗方法.
结论:
- 有效管理BK病毒感染需要采取多方面的方法,平衡免疫抑制降低与向治疗.
- IVIG和病毒特异性T细胞疗法在治疗BK病毒感染方面取得了重大进展.
- 持续的研究对于优化治疗策略和改善移植接受者的长期结果至关重要.
相关概念视频
01:15Diabetes: Management and Pharmacotherapy
285
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
285
01:30Lytic Cycle of Bacteriophages
70.7K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
70.7K
01:28Pulmonary Tuberculosis V
180
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
180
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
305
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
305
01:28Pneumonia IV: Management
331
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
331
01:10Retrovirus Life Cycles
46.0K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
46.0K